<?xml version="1.0" encoding="UTF-8"?>
<p id="Par46">Potential DDIs were evaluated before the administration of DAAs using a web interaction-checker (available at 
 <ext-link ext-link-type="uri" xlink:href="http://www.hepdruginteractions.org" xmlns:xlink="http://www.w3.org/1999/xlink">www.hepdruginteractions.org</ext-link>) and changes in co-medications due to DDIs were also recorded. During treatment, all patients routinely underwent monthly monitoring, including clinical and laboratory assessment.
</p>
